company background image
PFE

Pfizer NYSE:PFE Stock Report

Last Price

US$51.08

Market Cap

US$286.7b

7D

4.6%

1Y

-3.7%

Updated

01 Dec, 2022

Data

Company Financials +
PFE fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends5/6

PFE Stock Overview

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Pfizer Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pfizer
Historical stock prices
Current Share PriceUS$51.08
52 Week HighUS$61.71
52 Week LowUS$41.45
Beta0.64
1 Month Change6.40%
3 Month Change11.77%
1 Year Change-3.70%
3 Year Change34.32%
5 Year Change43.89%
Change since IPO1,626.65%

Recent News & Updates

Pfizer, Roche, Lilly COVID treatments get draft recommendation from UK NHS advisors

Nov 16

Recent updates

Should You Be Adding Pfizer (NYSE:PFE) To Your Watchlist Today?

Oct 17
Should You Be Adding Pfizer (NYSE:PFE) To Your Watchlist Today?

Pfizer (NYSE:PFE) Seems To Use Debt Rather Sparingly

Sep 30
Pfizer (NYSE:PFE) Seems To Use Debt Rather Sparingly

Do Pfizer's (NYSE:PFE) Earnings Warrant Your Attention?

Jul 15
Do Pfizer's (NYSE:PFE) Earnings Warrant Your Attention?

These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Safely

Jun 29
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Safely

Shareholder Returns

PFEUS PharmaceuticalsUS Market
7D4.6%2.6%1.4%
1Y-3.7%15.5%-16.1%

Return vs Industry: PFE underperformed the US Pharmaceuticals industry which returned 15.5% over the past year.

Return vs Market: PFE exceeded the US Market which returned -16.1% over the past year.

Price Volatility

Is PFE's price volatile compared to industry and market?
PFE volatility
PFE Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: PFE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: PFE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
184979,000Albert Bourlahttps://www.pfizer.com

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands.

Pfizer Inc. Fundamentals Summary

How do Pfizer's earnings and revenue compare to its market cap?
PFE fundamental statistics
Market CapUS$286.73b
Earnings (TTM)US$29.95b
Revenue (TTM)US$99.88b

9.6x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PFE income statement (TTM)
RevenueUS$99.88b
Cost of RevenueUS$33.80b
Gross ProfitUS$66.08b
Other ExpensesUS$36.13b
EarningsUS$29.95b

Last Reported Earnings

Oct 02, 2022

Next Earnings Date

n/a

Earnings per share (EPS)5.34
Gross Margin66.16%
Net Profit Margin29.99%
Debt/Equity Ratio39.8%

How did PFE perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

30%

Payout Ratio